Ziccum AB Financials
| ZICC Stock | SEK 0.25 0.00 0.00% |
Ziccum |
Understanding current and past Ziccum AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ziccum AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Ziccum AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Ziccum AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ziccum AB. Check Ziccum AB's Beneish M Score to see the likelihood of Ziccum AB's management manipulating its earnings.
Ziccum AB Stock Summary
Ziccum AB competes with Acarix AS, BioArctic, and Combigene. Ziccum AB develops dry powder preparations of biological pharmaceuticals. The company was founded in 2017 and is headquartered in Lund, Sweden. Ziccum AB is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0011415595 |
| Business Address | Scheelevgen 22, Lund, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | ziccum.com |
| Phone | 46 7 09 61 55 99 |
| Currency | SEK - Swedish Kronor |
You should never invest in Ziccum AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Ziccum Stock, because this is throwing your money away. Analyzing the key information contained in Ziccum AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Ziccum AB Key Financial Ratios
Ziccum AB's financial ratios allow both analysts and investors to convert raw data from Ziccum AB's financial statements into concise, actionable information that can be used to evaluate the performance of Ziccum AB over time and compare it to other companies across industries.| Return On Equity | -0.98 | |||
| Return On Asset | -0.52 | |||
| Beta | 1.89 | |||
| Z Score | 19.2 |
Ziccum Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ziccum AB's current stock value. Our valuation model uses many indicators to compare Ziccum AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ziccum AB competition to find correlations between indicators driving Ziccum AB's intrinsic value. More Info.Ziccum AB is rated third in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ziccum AB's earnings, one of the primary drivers of an investment's value.Ziccum AB Systematic Risk
Ziccum AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ziccum AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Ziccum AB correlated with the market. If Beta is less than 0 Ziccum AB generally moves in the opposite direction as compared to the market. If Ziccum AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ziccum AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ziccum AB is generally in the same direction as the market. If Beta > 1 Ziccum AB moves generally in the same direction as, but more than the movement of the benchmark.
Ziccum AB January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ziccum AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ziccum AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ziccum AB based on widely used predictive technical indicators. In general, we focus on analyzing Ziccum Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ziccum AB's daily price indicators and compare them against related drivers.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 81.73 | |||
| Value At Risk | (20.34) | |||
| Potential Upside | 9.89 |
Additional Tools for Ziccum Stock Analysis
When running Ziccum AB's price analysis, check to measure Ziccum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ziccum AB is operating at the current time. Most of Ziccum AB's value examination focuses on studying past and present price action to predict the probability of Ziccum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ziccum AB's price. Additionally, you may evaluate how the addition of Ziccum AB to your portfolios can decrease your overall portfolio volatility.